Meeting Announcements
Modulating Immunosuppression in the Intrapleural Space of Malignant Pleural Mesothelioma and Predictive Biomarkers to Guide Treatment Decisions
Whole Brain Radiotherapy for Patients with Non–Small Cell Lung Cancer with EGFR Mutations—Why and When?
Are Liquid Biopsies Ready for Prime Time of Clinical Applications?
Exosomal Proteins in Lung Cancer: The Last Frontier in Liquid Biopsies
Comment on the Proposals for the Revision of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer
The Genetic Landscape of Malignant Pleural Mesothelioma: Results from Massively Parallel Sequencing
Brain Metastases from NSCLC: Radiation Therapy in the Era of Targeted Therapies
Lung Cancer Screening with Chest Computed Tomography in People Living with HIV: A Review by the Multidisciplinary CANCERVIH Working Group
The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics
Impact of Race on Treatment and Survival among U.S. Veterans with Early-Stage Lung Cancer
ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS Study
A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma
Exosomal Proteins as Diagnostic Biomarkers in Lung Cancer
Heterogeneity of EGFR Aberrations and Correlation with Histological Structures: Analyses of Therapy-Naive Isogenic Lung Cancer Lesions with EGFR Mutation
EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases
Adjuvant Chemotherapy for Patients with T2N0M0 NSCLC
A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma
Does Lymph Node Metastasis Have a Negative Prognostic Impact in Patients with NSCLC and M1a Disease?
Pleural Effusion of Patients with Malignant Mesothelioma Induces Macrophage-Mediated T Cell Suppression
Pleural Effusions from Patients with Mesothelioma Induce Recruitment of Monocytes and Their Differentiation into M2 Macrophages
Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma
Postoperative Radiation Therapy Is Associated with Longer Overall Survival in Completely Resected Stage II and III Thymoma—An Analysis of the International Thymic Malignancies Interest Group Retrospective Database
Circulating Tumor Cells Detected in the Tumor-Draining Pulmonary Vein Are Associated with Disease Recurrence after Surgical Resection of NSCLC
S768I Mutation in EGFR in Patients with Lung Cancer
Sclerosing Pneumocytoma with Lymph Node Metastasis
“Pseudoprogression” of Pulmonary Pleomorphic Carcinoma during Nivolumab Therapy
L718Q Mutation as New Mechanism of Acquired Resistance to AZD9291 in EGFR -Mutated NSCLC
Response of Malignant Thymoma to Sorafenib
A Case of Lung Adenocarcinoma Resistant to Crizotinib Harboring a Novel EML4-ALK Variant, Exon 6 of EML4 Fused to Exon 18 of ALK
Prognostic and Predictive Value of KRAS Mutation in NSCLC
Response to Yamamoto et al.